Showing results (101-110 of 489) with videos related to
Sort By:
Pageof 49
Science (New York, N.Y.)|July 3, 1987
T-cell tumor elimination as a result of T-cell receptor-mediated activationJ D Ashwell, D L Longo, S H BridgesThe New England Journal of Medicine|June 27, 1985
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotypeM Raffeld, L Neckers, D L Longo, et al.Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L LongoCancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L LongoJournal of the National Cancer Institute. Monographs|January 1, 1990
Late complications of Hodgkin's disease managementR C Young, M A Bookman, D L LongoBiochemical and Biophysical Research Communications|October 4, 1995
Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation productC C Li, R M Dai, D L LongoJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccinesR T Fischer, D L Longo, J J KennyCancer Treatment Reports|September 1, 1985
Deep venous thrombosis during therapy for Hodgkin's diseaseE J Seifter, R C Young, D L LongoThe Journal of Experimental Medicine|April 1, 1982
B lymphocyte immune response gene phenotype is genetically determinedH Y Tse, J J Mond, D L LongoJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clonesT T Hecht, D L Longo, L A MatisPageof 49